{"meta":{"query_hash":"8cdab27c62c0","filters":{"venue":"Recent Patents on Inflammation & Allergy Drug Discovery"},"cohort_total":29,"direct_labels_cover":0,"predictions_cover":29,"exported":29,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8cdab27c62c0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Recent+Patents+on+Inflammation+%26+Allergy+Drug+Discovery"},"results":[{"id":"W2004555055","doi":"10.2174/187221309789257423","title":"Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases","year":2009,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital","funders":"","keywords":"Monoclonal antibody; Chemokine receptor; Immunology; Chemokine; CCR1; Chemokine receptor CCR5; Antibody; Cancer research; Inflammation; Medicine; Biology","score_opus":0.046201222710284616,"score_gpt":0.3312707757642936,"score_spread":0.285069553054009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004555055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031495124,0.9616211,0.000051252122,0.0005868964,0.00032610615,0.0046187486,0.0005176421,0.0001277083,0.00065539335],"genre_scores_gemma":[0.0039746477,0.9883501,0.00006665931,0.00009661692,0.00033198675,0.00044381857,0.003827176,0.00008923338,0.0028197803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99559206,0.00045168816,0.0015222445,0.000875603,0.0009225155,0.0006359102],"domain_scores_gemma":[0.99741113,0.0004145706,0.0009874447,0.00046555692,0.0004393968,0.00028188014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003954935,0.0008369185,0.0021743341,0.00044795548,0.00018741091,0.00010352495,0.00028392882,0.000494005,0.00022291474],"category_scores_gemma":[0.00015742029,0.00060391444,0.00074881554,0.00040536,0.00020000641,0.00028610323,0.000110087654,0.00061169,0.000061473875],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029598242,0.00088472926,0.00007840861,0.011549171,0.0016344592,0.000043861823,0.00013102264,0.00011247322,0.0019411426,0.0013289595,0.0010317032,0.97830427],"study_design_scores_gemma":[0.0028242099,0.001855111,0.004222593,0.010313759,0.00065254455,0.00004478639,0.000085487394,0.00015858116,0.0017945886,0.00066254777,0.9764091,0.0009767046],"about_ca_topic_score_codex":0.000022785238,"about_ca_topic_score_gemma":0.0000059936337,"teacher_disagreement_score":0.9773275,"about_ca_system_score_codex":0.00029369674,"about_ca_system_score_gemma":0.00062812224,"threshold_uncertainty_score":0.99964124},"labels":[],"label_agreement":null},{"id":"W2056231252","doi":"10.2174/187221309789257414","title":"Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders","year":2009,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Asthma; Drug development; Drug; Drug delivery; Intensive care medicine; Pharmacology; Internal medicine; Nanotechnology; Materials science","score_opus":0.033075614434043416,"score_gpt":0.28582214760186103,"score_spread":0.2527465331678176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056231252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008769157,0.9846561,0.00004664135,0.00024223428,0.000978859,0.004620918,0.00008974634,0.000046467132,0.00054988277],"genre_scores_gemma":[0.00039664068,0.99545217,0.000056283036,0.000023525552,0.0001337154,0.00038716532,0.00093759625,0.000073138326,0.0025397753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957841,0.00028806482,0.0022777987,0.00057254423,0.00069469056,0.000382825],"domain_scores_gemma":[0.9967545,0.00040253496,0.0017260202,0.00058038556,0.00038993027,0.00014659994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005213236,0.00067519204,0.0018206886,0.0004655009,0.0002162832,0.000051672796,0.00019204823,0.00030308397,0.000049216862],"category_scores_gemma":[0.00005667182,0.00041525086,0.00056548,0.0003805072,0.000120231,0.00019413381,0.000039055343,0.00020496653,0.000018892055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030992963,0.0006072482,0.000006867303,0.0041895774,0.0014926938,0.0000032315888,0.00081177615,0.00041649363,0.0000086007385,0.0001434705,0.00040674306,0.9916034],"study_design_scores_gemma":[0.0021368263,0.0002945906,0.000073437965,0.008469079,0.0005988502,0.000008280582,0.0003587288,0.0002569009,0.0001565576,0.0000070546303,0.9872739,0.00036579635],"about_ca_topic_score_codex":0.000015790169,"about_ca_topic_score_gemma":0.000031509113,"teacher_disagreement_score":0.9912376,"about_ca_system_score_codex":0.0005992556,"about_ca_system_score_gemma":0.00077137793,"threshold_uncertainty_score":0.99982995},"labels":[],"label_agreement":null},{"id":"W2063234246","doi":"10.2174/187221308786241910","title":"Omalizumab: Not Only For Asthma","year":2008,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Omalizumab; Medicine; Dermatology; Asthma; Angioedema; Atopic dermatitis; Allergy; Immunoglobulin E; Anaphylactic reactions; Intensive care medicine; Dupilumab; Anaphylaxis; Immunology; Antibody","score_opus":0.06804893948847734,"score_gpt":0.343807907959913,"score_spread":0.27575896847143566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063234246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068955676,0.98680204,0.00009345956,0.0011031552,0.0011283329,0.0038605253,0.00035773576,0.00021118087,0.0057539837],"genre_scores_gemma":[0.00007905842,0.97065425,0.00010919593,0.00020144996,0.0009196343,0.00067451276,0.004682134,0.00020877557,0.022470996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99470985,0.00029555685,0.0015676458,0.001112028,0.0014061867,0.00090874045],"domain_scores_gemma":[0.99708813,0.0003591075,0.0007646416,0.0009793524,0.00041560858,0.00039316644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032110774,0.0009699293,0.0022293162,0.00084211945,0.00035126758,0.00017000851,0.0005043028,0.00060252514,0.00033482347],"category_scores_gemma":[0.00036358234,0.0007679074,0.0015161489,0.0006212608,0.0001431841,0.00048484904,0.00016029792,0.0008578698,0.0007422772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006676302,0.0004065129,0.0000017391637,0.007099784,0.0012337336,0.00010706287,0.000057611876,0.000033063065,0.000005348232,0.0022288484,0.012445864,0.9757128],"study_design_scores_gemma":[0.0018292018,0.0004870529,0.00005268681,0.011685317,0.000052086332,0.0001302245,0.000027403357,0.00004592783,0.000068513335,0.000032691612,0.9849015,0.0006873783],"about_ca_topic_score_codex":0.000024125786,"about_ca_topic_score_gemma":0.00006118187,"teacher_disagreement_score":0.9750254,"about_ca_system_score_codex":0.0006166484,"about_ca_system_score_gemma":0.0014929046,"threshold_uncertainty_score":0.9994772},"labels":[],"label_agreement":null},{"id":"W2069668917","doi":"10.2174/1872213x07666131229110501","title":"Hepatic Manifestations in Juvenile Systemic Lupus Erythematosus","year":2014,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Juvenile; Medicine; Dermatology; Pathology; Biology","score_opus":0.031471372369026585,"score_gpt":0.29497075312028403,"score_spread":0.26349938075125745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069668917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028836539,0.9629328,0.00006987432,0.00016771458,0.0017368852,0.003270252,0.00017434712,0.00016119218,0.0026503445],"genre_scores_gemma":[0.0032459935,0.98820955,0.000022380535,0.00006964859,0.00027234352,0.0005423575,0.003282235,0.00012215381,0.004233342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99566257,0.00062170293,0.001847825,0.00063371036,0.000727041,0.0005071313],"domain_scores_gemma":[0.99731296,0.00022669665,0.0010511215,0.0010081381,0.00016707275,0.00023402396],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041880365,0.0007111381,0.0020444419,0.0006687854,0.00013629156,0.00014527042,0.00033370216,0.0003008889,0.00022982403],"category_scores_gemma":[0.00019206492,0.0005773538,0.0006705598,0.00048262638,0.00005507583,0.0004533235,0.0001281378,0.0006057589,0.0008635996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046210192,0.0020959398,0.0025905296,0.13480397,0.0018056929,0.00070040085,0.0010314652,0.00054016174,0.000009426753,0.0031948523,0.005080098,0.84768534],"study_design_scores_gemma":[0.0025968426,0.0001637375,0.00070721266,0.09029939,0.0011406555,0.0007596896,0.00032374024,0.00023275144,0.000004276115,0.0001113166,0.90273094,0.00092945126],"about_ca_topic_score_codex":0.00009375817,"about_ca_topic_score_gemma":0.000040474923,"teacher_disagreement_score":0.89765084,"about_ca_system_score_codex":0.0009057386,"about_ca_system_score_gemma":0.000599664,"threshold_uncertainty_score":0.99991435},"labels":[],"label_agreement":null},{"id":"W2077352371","doi":"10.2174/187221308786241965","title":"Seasonal Allergic Rhinitis","year":2008,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dermatology; Medicine","score_opus":0.043719673521193984,"score_gpt":0.2919180494381814,"score_spread":0.2481983759169874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077352371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007636828,0.974329,0.00012106931,0.00062295794,0.0015650326,0.002043841,0.00018147493,0.00029375314,0.020079175],"genre_scores_gemma":[0.00011523835,0.9761204,0.000097382916,0.00033475878,0.0013107486,0.00020891911,0.0096011795,0.00022545231,0.011985933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429595,0.00043433855,0.0018520053,0.0011100887,0.0015878917,0.0007197253],"domain_scores_gemma":[0.9969108,0.00021624597,0.0011664178,0.000899176,0.00039513904,0.00041219138],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020816181,0.0011320475,0.002511116,0.00059209,0.0003272111,0.00019713833,0.00031890217,0.00064551196,0.00090134295],"category_scores_gemma":[0.00019034963,0.00093566376,0.0011529507,0.0006143974,0.00013043114,0.0006207411,0.00013766337,0.0008882489,0.001517831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018129262,0.00036210712,0.0000075637795,0.0027300925,0.0013254452,0.00073716865,0.00018549486,0.00012544364,0.0000017889791,0.0013424557,0.020404503,0.97259665],"study_design_scores_gemma":[0.001372049,0.00012718451,0.00009121377,0.013909035,0.0002702842,0.00064965204,0.000040365496,0.0001719624,0.000008149967,0.000041533414,0.9824841,0.00083446724],"about_ca_topic_score_codex":0.000019771178,"about_ca_topic_score_gemma":0.000016782315,"teacher_disagreement_score":0.9717622,"about_ca_system_score_codex":0.00071846496,"about_ca_system_score_gemma":0.000972803,"threshold_uncertainty_score":0.9993094},"labels":[],"label_agreement":null},{"id":"W2087825633","doi":"10.2174/187221311794474874","title":"Polymorphisms in TOLL-Like Receptor Genes and their Roles in Allergic Asthma and Atopy","year":2011,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University","funders":"Canadian Institutes of Health Research; American Asthma Foundation","keywords":"Atopy; Asthma; Immunology; Medicine; Respiratory Hypersensitivity; Gene; Receptor; Toll-like receptor; Dermatology; Genetics; Biology; Internal medicine; Immune system; Innate immune system","score_opus":0.028381727388715215,"score_gpt":0.266857724411438,"score_spread":0.2384759970227228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087825633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.106225155,0.89147973,0.000004084823,0.00014780211,0.00034216448,0.0012467669,0.00007577099,0.00004961116,0.00042891182],"genre_scores_gemma":[0.0016602859,0.9959985,0.0000210676,0.00013166106,0.00023230951,0.00025458,0.00054648385,0.000100199846,0.0010548844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667,0.000402672,0.0012384801,0.0008610245,0.00033577878,0.000492042],"domain_scores_gemma":[0.99851704,0.000112139285,0.0005380076,0.0004804337,0.000060750062,0.0002916075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030727914,0.00080536446,0.0017518423,0.00079012907,0.00008404644,0.000096362295,0.00019109162,0.00042329586,0.00017759818],"category_scores_gemma":[0.000050017396,0.000572537,0.00027992367,0.0003528741,0.00014357074,0.0004360638,0.00017242912,0.00045880015,0.000060490842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002980342,0.00030168847,0.0010521272,0.002250241,0.00020149676,0.00006600685,0.00038704395,0.0000102431195,0.000027590135,0.00020928383,0.0002178861,0.99497837],"study_design_scores_gemma":[0.0015557304,0.00013490743,0.0029637853,0.014335754,0.00006437111,0.00003270646,0.00026382506,0.000019804944,0.00005304498,0.000038032227,0.97993106,0.0006069764],"about_ca_topic_score_codex":0.000048453712,"about_ca_topic_score_gemma":0.00022589696,"teacher_disagreement_score":0.99437135,"about_ca_system_score_codex":0.00022694573,"about_ca_system_score_gemma":0.0003368532,"threshold_uncertainty_score":0.9996726},"labels":[],"label_agreement":null},{"id":"W2110902454","doi":"10.2174/187221309788489760","title":"CTLA-4Ig: Uses and Future Directions","year":2009,"lang":"en","type":"article","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"CD80; Abatacept; CTLA-4; CD86; Immunology; Medicine; Cytotoxic T cell; Rheumatoid arthritis; CD28; Immune system; Co-stimulation; T cell; Computational biology; Antibody; Biology; Genetics","score_opus":0.01089703861054202,"score_gpt":0.21918889093279487,"score_spread":0.20829185232225284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110902454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978891,0.0044317665,0.000028856011,0.006880953,0.0024817616,0.00032159456,0.00003060463,0.00020754522,0.0067258957],"genre_scores_gemma":[0.954135,0.032219544,0.00002375356,0.0005406536,0.00031276504,0.00003407454,0.00048964465,0.00002375922,0.012220802],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983698,0.00022926377,0.00045049985,0.00044916332,0.00007800965,0.000423247],"domain_scores_gemma":[0.9992368,0.000071974704,0.00021457244,0.00034824648,0.00008958033,0.0000388036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013330545,0.00031141852,0.00031165307,0.00020732376,0.0003957075,0.0000821368,0.00019143602,0.0002842341,0.0005386919],"category_scores_gemma":[0.000030268902,0.0002628805,0.00010307878,0.00019218565,0.00012530579,0.00050137413,0.000058040914,0.0003467686,0.0005669645],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041457886,0.00038544938,0.00041658862,0.000011414196,0.0002918782,0.000007885401,0.0005608904,0.000041187282,0.8701389,0.006293961,0.005809809,0.11562745],"study_design_scores_gemma":[0.0016552764,0.00018780243,0.010500825,0.00004870001,0.000030024308,0.000025637913,0.00035278828,0.0000046455807,0.19467995,0.00057271664,0.7915889,0.0003527721],"about_ca_topic_score_codex":0.000036317015,"about_ca_topic_score_gemma":0.00003829583,"teacher_disagreement_score":0.78577906,"about_ca_system_score_codex":0.000070570975,"about_ca_system_score_gemma":0.00004492706,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2124602421","doi":"10.2174/187221312798889248","title":"Antipsoriatic Drug Development: Challenges and New Emerging Therapies","year":2012,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; National Psoriasis Foundation","keywords":"Psoriasis; Medicine; Psoriatic arthritis; Context (archaeology); Dermatology; Disease; Drug; Population; Apremilast; Dosing; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.1090490688260096,"score_gpt":0.2849487188563823,"score_spread":0.17589965003037267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124602421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054721897,0.9897775,0.00000657862,0.00031136282,0.0004234356,0.0002921255,0.000020486781,0.00013532293,0.0035609836],"genre_scores_gemma":[0.0011508382,0.9942579,0.00007656457,0.000017691502,0.0008561712,0.000113818925,0.00032021813,0.000074535754,0.0031322313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969106,0.0002229809,0.0010088152,0.00076071906,0.0005229057,0.0005739938],"domain_scores_gemma":[0.9979319,0.00040267667,0.00093154405,0.0004617779,0.000049723913,0.00022239109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004251656,0.0008281599,0.0014364519,0.00015857404,0.00020720196,0.00018116696,0.00039077166,0.00037895984,0.00066214835],"category_scores_gemma":[0.00009558709,0.00056625914,0.00031453057,0.00011623564,0.000054582244,0.00059061137,0.0002207959,0.00043144028,0.00016596096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024645467,0.00014557011,0.000013425093,0.0042896396,0.0006029446,0.0000026319397,0.0005971038,9.728401e-7,0.000029101331,0.00033782038,0.0000860024,0.99387014],"study_design_scores_gemma":[0.00025774672,0.0000062402137,0.00013281984,0.0067531816,0.0001517934,0.0000042333954,0.00018536347,0.0000020343416,0.00050359993,0.00010606646,0.9911764,0.0007205223],"about_ca_topic_score_codex":0.000013540531,"about_ca_topic_score_gemma":0.000033616787,"teacher_disagreement_score":0.99314964,"about_ca_system_score_codex":0.00022130752,"about_ca_system_score_gemma":0.00016718663,"threshold_uncertainty_score":0.9996789},"labels":[],"label_agreement":null},{"id":"W2148183280","doi":"10.2174/187221309787158434","title":"Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease","year":2009,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Inflammatory bowel disease; Hypoxia-inducible factors; Hypoxia (environmental); Vascular endothelial growth factor; Inflammation; Medicine; Signal transduction; Immunology; Gastrointestinal tract; Transcription factor; Cancer research; Pathology; Biology; Disease; Internal medicine; Cell biology; Chemistry; Gene","score_opus":0.04661507366339639,"score_gpt":0.31050963133566745,"score_spread":0.26389455767227105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148183280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073363194,0.988064,0.00038388214,0.00021499058,0.00089327095,0.0025416766,0.00050162285,0.000020180314,0.000044044467],"genre_scores_gemma":[0.0012133202,0.99349016,0.000046581026,0.00006351307,0.0014424045,0.0010470507,0.0021211293,0.0000806741,0.0004951443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724215,0.00020804045,0.0011623107,0.0006943167,0.0002531369,0.000440041],"domain_scores_gemma":[0.9978616,0.00014697642,0.00088965596,0.00082061917,0.00016325658,0.00011787894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023945814,0.00059396826,0.00079690706,0.0002037656,0.0001853733,0.000089906134,0.00041783266,0.00026971978,0.000012149041],"category_scores_gemma":[0.00006365548,0.0004271049,0.0006908146,0.00019763749,0.0000637345,0.00003383721,0.00004739985,0.00014766224,0.000005795456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002187851,0.00041795956,0.00005742022,0.0009900522,0.00070677727,5.5802843e-7,0.00014081829,0.003174269,0.0046288073,0.00023876994,0.00028592988,0.98913985],"study_design_scores_gemma":[0.0008527765,0.000118333,0.0006257895,0.0009768958,0.00030582692,6.7937344e-7,0.000044092005,0.00003232208,0.0013257547,0.00008215194,0.99519473,0.0004406456],"about_ca_topic_score_codex":0.000014141806,"about_ca_topic_score_gemma":0.00003147836,"teacher_disagreement_score":0.9949088,"about_ca_system_score_codex":0.00020572564,"about_ca_system_score_gemma":0.00056687475,"threshold_uncertainty_score":0.9998181},"labels":[],"label_agreement":null},{"id":"W2153097437","doi":"10.2174/187221309788489733","title":"Seasonal and Perennial Allergic Conjunctivitis","year":2009,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Antihistamine; Allergic conjunctivitis; Dermatology; Intensive care medicine; Allergy; Anesthesia; Immunology","score_opus":0.02969351301042768,"score_gpt":0.2852912957952687,"score_spread":0.255597782784841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153097437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008158437,0.9847733,0.000024836598,0.0007682902,0.0007927366,0.0014250415,0.00009661879,0.00012970796,0.0038310247],"genre_scores_gemma":[0.00039771784,0.99045354,0.00003340728,0.00027379688,0.00078933215,0.00009393844,0.0016752038,0.00009591618,0.0061871647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966307,0.00026736586,0.0009123293,0.0008309962,0.0008417676,0.00051683804],"domain_scores_gemma":[0.9983017,0.00011462917,0.0005477837,0.0005857772,0.00014331826,0.00030681366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002406557,0.0008100172,0.0019026622,0.00030467968,0.00014975229,0.00021236809,0.00017578885,0.0004273549,0.0003332826],"category_scores_gemma":[0.00007459581,0.00064925244,0.0006224634,0.00025857432,0.00006854144,0.00047181628,0.00009251941,0.00066773023,0.00034800812],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017366708,0.00019777758,0.00004597847,0.0024053766,0.00082911627,0.00014268028,0.000056685018,0.0000075503954,0.0000056118765,0.0007507588,0.00087919744,0.9945056],"study_design_scores_gemma":[0.0014071616,0.00021282477,0.00051695737,0.0117905345,0.0005757488,0.00004321119,0.00003447092,0.000032240812,0.000011854583,0.000040877152,0.9847334,0.0006007028],"about_ca_topic_score_codex":0.000016426124,"about_ca_topic_score_gemma":0.000028206881,"teacher_disagreement_score":0.9939049,"about_ca_system_score_codex":0.00033026523,"about_ca_system_score_gemma":0.0005061784,"threshold_uncertainty_score":0.9995959},"labels":[],"label_agreement":null},{"id":"W2161160453","doi":"10.2174/187221310789895577","title":"JAK3 Inhibitors in Organ Transplantation and Autoimmune Disease","year":2009,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute","keywords":"Transplantation; Janus kinase 3; Organ transplantation; Janus kinase; Medicine; Tyrosine kinase; Immune system; Immunology; Immunodeficiency; Disease; Autoimmune disease; Immunity; Cancer research; T cell; Pathology; Internal medicine; Antibody; Cytokine; Antigen-presenting cell; Receptor","score_opus":0.027341624420116974,"score_gpt":0.2872057695918867,"score_spread":0.25986414517176976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161160453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02222707,0.973897,0.000017462286,0.00045767645,0.0006638944,0.0019481645,0.0001615836,0.000095776566,0.0005313742],"genre_scores_gemma":[0.0016717075,0.9923941,0.00002156188,0.000105482584,0.0002880162,0.000108172106,0.004520128,0.000068753594,0.0008220826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969751,0.00032654614,0.001138994,0.0005885678,0.0005568427,0.0004138997],"domain_scores_gemma":[0.99853575,0.00008338612,0.00047089605,0.000529577,0.00008438508,0.00029601462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024789287,0.00060984574,0.0012382494,0.0005431554,0.00012549979,0.00013737417,0.00016625258,0.00022387286,0.000104396415],"category_scores_gemma":[0.00007260132,0.0005022597,0.00035645367,0.00044099466,0.00006074499,0.00063922425,0.00005697051,0.0005179962,0.000075129225],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005401445,0.0005551047,0.00029125568,0.010589504,0.00026816002,0.00017688164,0.00022870196,0.000049903178,0.0000058218634,0.00020896328,0.00029602408,0.9867895],"study_design_scores_gemma":[0.0033156658,0.00017812767,0.04037431,0.05241218,0.0013294619,0.000026275391,0.00008978534,0.000098966164,0.000017130098,0.00012038736,0.90110135,0.0009363412],"about_ca_topic_score_codex":0.00005634833,"about_ca_topic_score_gemma":0.000012678205,"teacher_disagreement_score":0.9858532,"about_ca_system_score_codex":0.0004010667,"about_ca_system_score_gemma":0.000478928,"threshold_uncertainty_score":0.9997429},"labels":[],"label_agreement":null},{"id":"W2287581582","doi":"10.2174/187221307780979892","title":"Vcsa1 Gene Peptides for the Treatment of Inflammatory and Allergic Reactions","year":2007,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Pentapeptide repeat; Peptide; Gene; Peptide sequence; Submandibular gland; Biology; Biochemistry; Prohormone; Allergic inflammation; Chemistry; Inflammation; Immunology; Hormone; Endocrinology","score_opus":0.06294170138481851,"score_gpt":0.3337765403493919,"score_spread":0.2708348389645734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287581582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066638975,0.98845154,0.00011303427,0.00016665523,0.0005516325,0.0034181024,0.00019933673,0.00006496077,0.0003708132],"genre_scores_gemma":[0.00015651685,0.993747,0.000054180495,0.000045945035,0.00070639525,0.000699847,0.00078296656,0.00009510167,0.0037120543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970556,0.00014179986,0.0013593034,0.00054511154,0.0005170956,0.00038112586],"domain_scores_gemma":[0.9972629,0.00063324004,0.0009834968,0.0006831011,0.00022139598,0.00021586484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027840145,0.00064240315,0.0013694875,0.0003907687,0.00025264046,0.00006583744,0.000161556,0.00028432297,0.000055455104],"category_scores_gemma":[0.00008698463,0.0003775364,0.0008446027,0.00023391501,0.00018633784,0.00021451106,0.000038620896,0.00018093175,0.000030570303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036616618,0.00052293,0.000039906303,0.0050731557,0.0014160381,0.000021218118,0.00013545905,0.00010407589,0.000028127459,0.00028028397,0.0004442891,0.9915683],"study_design_scores_gemma":[0.0013514349,0.00041253844,0.00038230207,0.004725152,0.0010084127,0.00002114552,0.00015609643,0.00002722499,0.00019377464,0.00001545961,0.9913803,0.00032619506],"about_ca_topic_score_codex":0.000014623236,"about_ca_topic_score_gemma":0.000026036787,"teacher_disagreement_score":0.9912422,"about_ca_system_score_codex":0.0003663924,"about_ca_system_score_gemma":0.00047155572,"threshold_uncertainty_score":0.9998677},"labels":[],"label_agreement":null},{"id":"W2320940503","doi":"10.2174/187221310793564209","title":"Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions","year":2010,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Omalizumab; Asthma; Medicine; Monoclonal antibody; Monoclonal; Intensive care medicine; Allergic asthma; Immunology; Immunoglobulin E; Antibody","score_opus":0.029219319547421244,"score_gpt":0.31151511801066284,"score_spread":0.2822957984632416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320940503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019186981,0.99156,0.000038554423,0.0008639101,0.0014622972,0.0028063478,0.00055491505,0.0001636211,0.00063164736],"genre_scores_gemma":[0.000024149222,0.99022716,0.00014793218,0.00015062482,0.0021713425,0.0011334963,0.0031779595,0.00012713872,0.002840167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970575,0.00018395743,0.0010524695,0.0007674546,0.0005306982,0.0004079507],"domain_scores_gemma":[0.99769527,0.00019683236,0.00085978,0.00065599836,0.00025583396,0.00033629287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002041315,0.00068150595,0.0013200941,0.00056995125,0.00041313897,0.0001830204,0.00020176008,0.0005725037,0.00013014903],"category_scores_gemma":[0.00018053854,0.00051461154,0.00048787982,0.0003841081,0.00012859743,0.0004526712,0.000080968326,0.0005879594,0.000089416986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120217715,0.00039403467,0.000025897476,0.0037263872,0.0003618498,0.0000091985185,0.00005954232,7.8929645e-7,0.0000044861827,0.0008969886,0.0021385555,0.99226207],"study_design_scores_gemma":[0.001379845,0.00013986729,0.0004566598,0.0043841973,0.0005563099,0.000029283285,0.00008786639,0.00001073045,0.0000134164175,0.000029386783,0.99242884,0.0004836249],"about_ca_topic_score_codex":0.000005101574,"about_ca_topic_score_gemma":0.000031898908,"teacher_disagreement_score":0.99177843,"about_ca_system_score_codex":0.00020911013,"about_ca_system_score_gemma":0.0007221484,"threshold_uncertainty_score":0.9997305},"labels":[],"label_agreement":null},{"id":"W2474289941","doi":"10.2174/187221310793564272","title":"Editorial: [Monoclonal Antibodies in the Treatment of Asthma(Guest Editor: Moshe Ben-Shoshan)]","year":2010,"lang":"en","type":"editorial","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Asthma; Medicine; Monoclonal antibody; Antibody; Immunology","score_opus":0.016775605154623074,"score_gpt":0.3008386742189113,"score_spread":0.28406306906428824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474289941","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07931443,0.00067389966,0.0000022700544,0.0022532432,0.91374296,0.0014109251,0.0009387997,0.000051402076,0.0016120828],"genre_scores_gemma":[0.0009858634,0.049545333,0.000056215315,0.000038896895,0.93601924,0.00028124172,0.007803945,0.00010444679,0.005164831],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99175304,0.00042790658,0.0015652698,0.0009640255,0.00441895,0.00087082107],"domain_scores_gemma":[0.9954534,0.0015106524,0.0008162048,0.0010495613,0.0009289666,0.00024121016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008716925,0.00096622144,0.0014064875,0.00061504374,0.00023558617,0.00022990209,0.0007365439,0.0012563146,0.00019395836],"category_scores_gemma":[0.0005546472,0.0006205925,0.0006282047,0.00043412554,0.00033151542,0.00045080835,0.00013287184,0.0018420595,0.00017157602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028333517,0.0018713252,0.0005952303,0.00033962415,0.0005341468,0.00006552462,0.000954672,0.000055644694,0.0009330309,0.00012314493,0.98682106,0.0048732623],"study_design_scores_gemma":[0.0029056869,0.0012892499,0.0014395481,0.00072005606,0.00008866465,0.0000040120935,0.00023429458,0.000026656822,0.0033313062,0.00009631903,0.9893461,0.0005181485],"about_ca_topic_score_codex":0.0013745598,"about_ca_topic_score_gemma":0.0013354762,"teacher_disagreement_score":0.07832857,"about_ca_system_score_codex":0.00054533913,"about_ca_system_score_gemma":0.0010712727,"threshold_uncertainty_score":0.99962455},"labels":[],"label_agreement":null},{"id":"W2597574608","doi":"10.2174/1872213x11666170110162344","title":"Cutaneous Larva Migrans","year":2017,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Cutaneous larva migrans; Ivermectin; Dermatology; Pathognomonic; Visceral larva migrans; Toxocara canis; Medicine; Larva; Pathology; Larva migrans; Biology; Veterinary medicine; Helminthiasis; Helminths; Immunology; Ecology; Disease","score_opus":0.10934007122511744,"score_gpt":0.3700056040117854,"score_spread":0.26066553278666793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597574608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003272041,0.9712082,0.000050731418,0.0011003776,0.0010210887,0.0020580888,0.0004957967,0.00021823165,0.023520293],"genre_scores_gemma":[0.00012622833,0.9801534,0.000029816503,0.00025127508,0.0003454085,0.00027023416,0.004699961,0.00009230202,0.0140313925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966947,0.0002048718,0.0012496187,0.00059989985,0.0007392296,0.0005116684],"domain_scores_gemma":[0.9971043,0.00016146622,0.0010238787,0.0011466184,0.00020080598,0.00036291807],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011685045,0.0007075831,0.00186214,0.000320817,0.0003375893,0.00035629768,0.0004182443,0.0003864448,0.0006493127],"category_scores_gemma":[0.00035609654,0.0005140793,0.0010648344,0.00018645612,0.00011983076,0.00050287344,0.00010911512,0.00053496595,0.0023775918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008836506,0.000401709,0.000024450217,0.0058055134,0.0007144377,0.0004192903,0.00004540838,0.000024176034,7.033813e-7,0.0014832021,0.0070516746,0.9839411],"study_design_scores_gemma":[0.0005787524,0.0000782091,0.00009557352,0.012826606,0.00071486674,0.00020970276,0.000028349988,0.000024619389,0.000002802514,0.00010127893,0.984838,0.0005012034],"about_ca_topic_score_codex":0.000021396914,"about_ca_topic_score_gemma":0.000018138548,"teacher_disagreement_score":0.98343986,"about_ca_system_score_codex":0.0002680486,"about_ca_system_score_gemma":0.00048670836,"threshold_uncertainty_score":0.99973106},"labels":[],"label_agreement":null},{"id":"W2785696424","doi":"10.2174/1872213x12666180129165718","title":"Bacterial Conjunctivitis in Childhood: Etiology, Clinical Manifestations, Diagnosis, and Management","year":2018,"lang":"en","type":"article","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Bacterial Conjunctivitis; Medicine; Moraxella catarrhalis; Streptococcus pneumoniae; Dermatology; Allergic conjunctivitis; Haemophilus influenzae; Antibiotics; Pediatrics; Immunology; Microbiology; Allergy","score_opus":0.02352674272896899,"score_gpt":0.30356585835554223,"score_spread":0.28003911562657324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785696424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926752,0.000048936265,0.000055067263,0.0017514264,0.0009455927,0.00084452936,0.000024921912,0.000049186936,0.003605152],"genre_scores_gemma":[0.9826184,0.015181295,0.00020103139,0.0002935246,0.00036381205,0.00024211616,0.00047230077,0.000024284609,0.0006032532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836946,0.00018074577,0.00056862965,0.00042717103,0.00021382551,0.00024018368],"domain_scores_gemma":[0.9993028,0.000078961035,0.00016355033,0.00027186563,0.000075998854,0.00010681673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026321007,0.00020487038,0.00028325722,0.00024039105,0.00012081988,0.000068611305,0.00005125127,0.000105634055,0.00028207514],"category_scores_gemma":[0.0000654115,0.00017883177,0.00008053919,0.00016791228,0.00012750825,0.00033432562,0.00006506843,0.00014242185,0.00015331448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086011144,0.0027228098,0.83862966,0.00008558443,0.0009352529,0.00023765981,0.00027362898,0.00003158755,0.000092521295,0.0053921025,0.002465682,0.14827338],"study_design_scores_gemma":[0.004942638,0.00042084148,0.9546511,0.00023797872,0.00006671696,0.000024253352,0.00008873348,0.000031996286,0.00043510774,0.00019920773,0.038733833,0.00016757107],"about_ca_topic_score_codex":0.00005473549,"about_ca_topic_score_gemma":0.00032440727,"teacher_disagreement_score":0.14810582,"about_ca_system_score_codex":0.0001239237,"about_ca_system_score_gemma":0.000040930638,"threshold_uncertainty_score":0.72925484},"labels":[],"label_agreement":null},{"id":"W2925431145","doi":"10.2174/1872213x13666190328164931","title":"Chronic Urticaria: An Overview of Treatment and Recent Patents","year":2019,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Angioedema; Adverse effect; Population; Erythrocyte sedimentation rate; Randomized controlled trial; Clinical trial; Intensive care medicine; Dermatology; Pharmacotherapy; Internal medicine; Pediatrics","score_opus":0.10927532595434773,"score_gpt":0.35021794108731213,"score_spread":0.2409426151329644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925431145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030377633,0.9909899,0.000010315541,0.00042424243,0.0010267143,0.0028302963,0.00026156698,0.00008745696,0.0013317108],"genre_scores_gemma":[0.00017460868,0.9917812,0.000024262785,0.000041575408,0.00037693544,0.0002827606,0.004477147,0.0001222401,0.0027192817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595433,0.0003952621,0.0016377625,0.00090549706,0.00056902354,0.0005381308],"domain_scores_gemma":[0.9972298,0.00012863966,0.00095827086,0.0010935325,0.00024276554,0.0003469496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018728575,0.0008479758,0.0023189953,0.0004778509,0.0001255411,0.000098395976,0.00021808852,0.00058663986,0.0005621804],"category_scores_gemma":[0.00005456875,0.0006005126,0.00059348,0.00046266714,0.00011740013,0.00046440298,0.00010807284,0.00047381336,0.000294632],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120098775,0.00070100895,0.000035565816,0.0045213248,0.007030896,0.000029515302,0.00016095185,0.00009047545,0.000056906996,0.0021921864,0.00019939867,0.9848617],"study_design_scores_gemma":[0.002816276,0.0012829923,0.0002512588,0.019099845,0.009536166,0.000048722584,0.000050134568,0.00009312386,0.00008702953,0.000083734245,0.96603775,0.0006129912],"about_ca_topic_score_codex":0.000050738305,"about_ca_topic_score_gemma":0.00002592693,"teacher_disagreement_score":0.9842487,"about_ca_system_score_codex":0.0014964312,"about_ca_system_score_gemma":0.0011945389,"threshold_uncertainty_score":0.99964464},"labels":[],"label_agreement":null},{"id":"W2945149001","doi":"10.2174/1872213x13666190514105054","title":"Travelers’ Diarrhea: A Clinical Review","year":2019,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Travel-related health issues","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Rifaximin; Traveler's diarrhea; Diarrhea; Medicine; Azithromycin; Loperamide; Travel medicine; Intensive care medicine; Antibiotics; Internal medicine; Pediatrics; Environmental health; Pathology; Microbiology","score_opus":0.15683581577830724,"score_gpt":0.4266110315409056,"score_spread":0.2697752157625984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945149001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088551584,0.9828862,0.000021414664,0.002464966,0.0029866004,0.006414747,0.0001186181,0.00023791942,0.004780977],"genre_scores_gemma":[0.0000068382883,0.98048675,0.0000809094,0.0016028897,0.0011525862,0.00045438408,0.003388712,0.00026722864,0.012559713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98998266,0.0012426409,0.004826989,0.0015155991,0.0014646329,0.0009674662],"domain_scores_gemma":[0.9941638,0.00063915836,0.0024031473,0.0018071407,0.00034529556,0.0006414588],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017914206,0.0012713254,0.0056972355,0.00053388905,0.00013735026,0.00010359573,0.00055432087,0.0011221615,0.00088430673],"category_scores_gemma":[0.0007531822,0.00097370293,0.0018564615,0.0007998728,0.00012405773,0.00047182033,0.00015025178,0.0023333076,0.007064736],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118036485,0.000356179,0.00002431503,0.1073291,0.0011654779,0.00007510451,0.00005281088,0.000003886927,1.6261666e-7,0.00034616265,0.018605078,0.8719237],"study_design_scores_gemma":[0.0012044371,0.00019954321,0.00022104367,0.22339107,0.0015529712,0.00004224204,0.000010765682,0.0000075216353,0.0000015063009,0.000011378525,0.7727249,0.0006325946],"about_ca_topic_score_codex":0.0000278171,"about_ca_topic_score_gemma":0.00001420498,"teacher_disagreement_score":0.8712911,"about_ca_system_score_codex":0.0008278275,"about_ca_system_score_gemma":0.0018637864,"threshold_uncertainty_score":0.99996835},"labels":[],"label_agreement":null},{"id":"W2949782629","doi":"10.2174/1872213x13666190618124901","title":"Giardiasis: An Overview","year":2019,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Parasitic Infections and Diagnostics","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Giardia lamblia; Giardia; Diarrhea; Cryptosporidium; Metronidazole; Medicine; Outbreak; Intestinal parasite; Transmission (telecommunications); Feces; Biology; Immunology; Virology; Internal medicine; Microbiology; Veterinary medicine; Pathology; Helminths; Antibiotics","score_opus":0.10449437588848913,"score_gpt":0.3516838808504341,"score_spread":0.24718950496194497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949782629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034091916,0.9881666,0.00004154536,0.000050648232,0.0050343624,0.0012071729,0.0003903187,0.00015834448,0.004610132],"genre_scores_gemma":[0.000053704072,0.98531026,0.000010499947,0.00011822741,0.00025004105,0.00028987558,0.006925215,0.00009610091,0.006946085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626046,0.00092144083,0.0012096147,0.00082558865,0.00016097656,0.0006219256],"domain_scores_gemma":[0.9974313,0.00043964307,0.00082801725,0.0010723928,0.00015863031,0.00007001924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038438066,0.00079216796,0.0017610914,0.0004451257,0.00025405156,0.00016965566,0.00048722443,0.0007979149,0.0013439866],"category_scores_gemma":[0.00018151216,0.0006502295,0.0006953896,0.0003463665,0.00009065156,0.0006626051,0.00013985451,0.0007312473,0.013514317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039019124,0.0004361036,0.000012466846,0.0030885462,0.0013812482,0.000012385493,0.00007019148,0.00015544095,0.000014600621,0.0075932443,0.006989949,0.9802068],"study_design_scores_gemma":[0.00062862586,0.00010277572,0.000055847315,0.00678422,0.00054527185,0.000035394823,0.00003452005,0.0000023179298,0.000058581383,0.000063259635,0.9909895,0.00069967104],"about_ca_topic_score_codex":0.000042798132,"about_ca_topic_score_gemma":0.000023488807,"teacher_disagreement_score":0.98399955,"about_ca_system_score_codex":0.0003413597,"about_ca_system_score_gemma":0.00042263293,"threshold_uncertainty_score":0.99959487},"labels":[],"label_agreement":null},{"id":"W2983564427","doi":"10.2174/1872213x13666191026090713","title":"Onychomycosis: An Updated Review","year":2019,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Terbinafine; Medicine; Dermatology; Onycholysis; Itraconazole; Fluconazole; Nail (fastener); Nail disease; Trichophyton rubrum; Adverse effect; Dermatophyte; Randomized controlled trial; Nail plate; Antifungal; Surgery; Paronychia; Internal medicine","score_opus":0.06647076181280055,"score_gpt":0.3525064350650532,"score_spread":0.28603567325225265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983564427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016825872,0.99042785,0.0000043375585,0.00035516924,0.000868503,0.004201463,0.00034502172,0.00018075795,0.003448642],"genre_scores_gemma":[0.000016542175,0.9594889,0.000022343886,0.0006663447,0.00034094427,0.000499384,0.030234026,0.00017850737,0.008552983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995223,0.00042884177,0.0016059327,0.0011201841,0.0010453907,0.0005766664],"domain_scores_gemma":[0.9965096,0.00005642144,0.0011262931,0.0016008695,0.00024484337,0.00046198472],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024931494,0.0010345757,0.0028832413,0.00039519108,0.000114351154,0.00015636903,0.00037872329,0.00033573134,0.001597991],"category_scores_gemma":[0.000066040724,0.0007509253,0.0011490275,0.0005934019,0.000038917824,0.00076965766,0.000108363274,0.0004963292,0.0037244714],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014201744,0.000956981,0.000026928248,0.036364954,0.0020117415,0.00009582836,0.000011552484,0.000005261758,5.345874e-7,0.00020364113,0.015536192,0.9446444],"study_design_scores_gemma":[0.0012920116,0.00019119875,0.00009705219,0.10464187,0.0033476425,0.000025759033,0.00000875221,0.000006480771,0.0000031412815,0.0000127493495,0.8897929,0.0005804202],"about_ca_topic_score_codex":0.000020729252,"about_ca_topic_score_gemma":0.000007141141,"teacher_disagreement_score":0.94406396,"about_ca_system_score_codex":0.00067900046,"about_ca_system_score_gemma":0.00070967065,"threshold_uncertainty_score":0.9994942},"labels":[],"label_agreement":null},{"id":"W2999022157","doi":"10.2174/1872213x14666200106145624","title":"Tinea Capitis: An Updated Review","year":2020,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Tinea capitis; Dermatology; Medicine; Itraconazole; Trichophyton tonsurans; Scalp; Microsporum canis; Griseofulvin; Fluconazole; Terbinafine; Dermatophyte; Dermatoscopy; Hair loss; Trichophyton rubrum; Antifungal","score_opus":0.04551506738190548,"score_gpt":0.33248547702831766,"score_spread":0.2869704096464122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999022157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085609536,0.9923196,0.0000066453094,0.0010223346,0.0005208163,0.003148806,0.00047425224,0.00023508146,0.0021868872],"genre_scores_gemma":[0.000015269474,0.96072626,0.000032445467,0.00089489674,0.0005260494,0.0004448082,0.034397025,0.00017302916,0.0027901928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99546653,0.00040920125,0.0015818182,0.001062429,0.0009662356,0.00051378045],"domain_scores_gemma":[0.9970556,0.00004350838,0.001007943,0.0010289655,0.00021343686,0.0006505443],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016554784,0.0009874626,0.0027137455,0.0002558633,0.0001274726,0.00014602795,0.00033995078,0.0002686105,0.0015767918],"category_scores_gemma":[0.00010103612,0.0007430088,0.0009624672,0.00061858183,0.000046061206,0.00060749095,0.00011873639,0.000503861,0.0022579052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011911344,0.0005652744,0.00001137706,0.022712372,0.0016339273,0.00044940837,0.000020148571,0.000002394856,7.4142145e-7,0.0002037806,0.016677763,0.9576037],"study_design_scores_gemma":[0.0011639772,0.00019342647,0.00004470578,0.06377608,0.0025073101,0.000044849134,0.0000109365665,0.0000108035565,0.0000051024504,0.00001460544,0.9316654,0.00056278514],"about_ca_topic_score_codex":0.000026482201,"about_ca_topic_score_gemma":0.000009503117,"teacher_disagreement_score":0.9570409,"about_ca_system_score_codex":0.0005454832,"about_ca_system_score_gemma":0.00070449867,"threshold_uncertainty_score":0.9995021},"labels":[],"label_agreement":null},{"id":"W3004609518","doi":"10.2174/1872213x14666200204103714","title":"Acute Myocarditis in Children: An Overview of Treatment and Recent Patents","year":2020,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Myocarditis; Heart failure; Cardiogenic shock; Internal medicine; Palpitations; Chest pain; Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.10409962320399273,"score_gpt":0.37715490717284944,"score_spread":0.2730552839688567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004609518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030943988,0.96483296,0.000003734899,0.0004016253,0.00032744612,0.002683882,0.000341434,0.00005649911,0.00040844764],"genre_scores_gemma":[0.00044488627,0.9948891,0.000019486859,0.00005925573,0.00016154502,0.00037317208,0.0035326518,0.0000861048,0.00043380487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962809,0.00060135266,0.0013779004,0.00082940335,0.0004330571,0.00047738006],"domain_scores_gemma":[0.9982395,0.000058578145,0.0006185577,0.0006854255,0.00016450278,0.00023344018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024588793,0.0006955819,0.002335212,0.00064382376,0.00010362847,0.0000873174,0.00020517092,0.00038459388,0.00018324403],"category_scores_gemma":[0.000066010805,0.0005283247,0.00045788244,0.0007334236,0.00012366517,0.00051692064,0.0001630126,0.0005760395,0.00009810555],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021391815,0.0005834497,0.0007995664,0.001355163,0.0026218924,0.000040864077,0.00008936006,0.000012598059,0.000024112176,0.00013620856,0.0001226084,0.99400026],"study_design_scores_gemma":[0.0031234198,0.001908534,0.0049816426,0.00962326,0.00087531185,0.00011724136,0.000044861852,0.000028894345,0.00011567148,0.000028559187,0.97862136,0.00053121336],"about_ca_topic_score_codex":0.0001570019,"about_ca_topic_score_gemma":0.00003287786,"teacher_disagreement_score":0.99346906,"about_ca_system_score_codex":0.00092289975,"about_ca_system_score_gemma":0.00053852645,"threshold_uncertainty_score":0.9997168},"labels":[],"label_agreement":null},{"id":"W3039531970","doi":"10.2174/1872213x14666200705235757","title":"Human Ascariasis: An Updated Review","year":2020,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Ascaris lumbricoides; Ascariasis; Medicine; Ascaris; Abdominal pain; Cholecystitis; Diarrhea; Internal medicine; Surgery; Gallbladder; Helminths; Immunology","score_opus":0.049234995195138034,"score_gpt":0.3465580426919008,"score_spread":0.2973230474967628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039531970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000669435,0.99211705,0.000011334125,0.00069193187,0.0017009969,0.0013779118,0.00043470034,0.00022806312,0.0033710715],"genre_scores_gemma":[0.000020778301,0.9619176,0.000007913917,0.00040222885,0.00023445186,0.00031320303,0.029195381,0.000098534416,0.0078099007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957023,0.001055689,0.0016360038,0.00093169423,0.0001606009,0.00051366497],"domain_scores_gemma":[0.99749786,0.00006847568,0.0012690685,0.00088072073,0.00018235589,0.0001014957],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000268568,0.00083043374,0.0020911782,0.00028611234,0.0003760382,0.00015694999,0.00072148157,0.00051967485,0.0040921723],"category_scores_gemma":[0.00007215945,0.00068254734,0.00076117966,0.0004229195,0.00007709166,0.0007957706,0.00016646943,0.0010409765,0.0070540393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042741198,0.00038117144,0.0000026070995,0.00452069,0.0026333362,0.000028126782,0.00008105156,0.000009814254,0.00015115768,0.002833326,0.07251744,0.91679853],"study_design_scores_gemma":[0.00040130652,0.00010331603,0.000016215408,0.0195724,0.00077212893,0.000041119998,0.00002677197,7.8645684e-7,0.00006039312,0.000028476452,0.9783309,0.00064619386],"about_ca_topic_score_codex":0.00005282847,"about_ca_topic_score_gemma":0.00006473452,"teacher_disagreement_score":0.91615236,"about_ca_system_score_codex":0.0002951287,"about_ca_system_score_gemma":0.00025743688,"threshold_uncertainty_score":0.99956256},"labels":[],"label_agreement":null},{"id":"W3045764501","doi":"10.2174/1872213x14999200728145822","title":"Childhood Alopecia Areata: An Overview of Treatment and Recent Patents","year":2020,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Alopecia areata; Hair loss; Scalp; Medicine; Dermatology; Minoxidil; Body hair; Pathognomonic; Disease; Pathology","score_opus":0.09556994993165867,"score_gpt":0.336863871971027,"score_spread":0.24129392203936834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045764501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003441031,0.99011654,0.000009434317,0.0005990366,0.0004985447,0.0029360284,0.0004044175,0.00011453216,0.0018804282],"genre_scores_gemma":[0.00025447342,0.99209577,0.00004359491,0.0001949514,0.00035281706,0.00028229438,0.006029903,0.00014489295,0.0006013311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954616,0.00040847983,0.0017469603,0.0011132765,0.0007086561,0.00056101894],"domain_scores_gemma":[0.9972128,0.0000942499,0.0009920892,0.00088230334,0.00019724885,0.00062129874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002018081,0.0010809717,0.0028739672,0.00042400302,0.00012677093,0.00011787917,0.000276754,0.0003852851,0.00030164086],"category_scores_gemma":[0.0001502508,0.0008059847,0.00062018645,0.00059903867,0.000090723,0.0005791742,0.00013785191,0.00038057196,0.00015266894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022255155,0.00094246713,0.00011745243,0.0053832657,0.0012409873,0.000045675286,0.00039885094,0.00001533996,0.0000032702944,0.00032129034,0.00039150947,0.9909173],"study_design_scores_gemma":[0.0028479209,0.00091393286,0.0007021233,0.01193624,0.0010142492,0.000028947083,0.00016244323,0.0000150863825,0.000036280107,0.000052753014,0.9816497,0.00064030977],"about_ca_topic_score_codex":0.00006693074,"about_ca_topic_score_gemma":0.0000789133,"teacher_disagreement_score":0.99027705,"about_ca_system_score_codex":0.00065871497,"about_ca_system_score_gemma":0.000899279,"threshold_uncertainty_score":0.9994391},"labels":[],"label_agreement":null},{"id":"W3048710726","doi":"10.2174/1872213x14666200810152246","title":"Nummular Eczema: An Updated Review","year":2020,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Dermatology","score_opus":0.044022076150568086,"score_gpt":0.3286574115018217,"score_spread":0.2846353353512536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048710726","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011079671,0.99265337,0.000010308413,0.0011938908,0.00061276124,0.002851006,0.00023606636,0.0002609044,0.0020709021],"genre_scores_gemma":[0.000012704184,0.97422075,0.000041798212,0.0015227603,0.0007925143,0.0003489685,0.0216006,0.00018099445,0.0012788943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507004,0.0005010482,0.0017323457,0.0010893705,0.0010417101,0.0005655093],"domain_scores_gemma":[0.99674606,0.00008829743,0.0010153091,0.0012456097,0.0002446145,0.0006601054],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029559492,0.0009921397,0.0030284699,0.00027888105,0.00012655798,0.00018287999,0.00045993875,0.00033105107,0.0018302221],"category_scores_gemma":[0.00027067697,0.0007599778,0.0011303943,0.000723575,0.000058328522,0.00068856607,0.00015955516,0.00060805125,0.00157857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009606311,0.0004340924,0.000010099179,0.035330266,0.0011146604,0.00019419807,0.000021815951,0.000010447521,0.0000022533504,0.00033507677,0.031174088,0.9312769],"study_design_scores_gemma":[0.0007558123,0.00014198804,0.000027696004,0.07475631,0.0017249237,0.000017914701,0.000014784998,0.000033009062,0.0000124694025,0.000027778544,0.9218348,0.0006524613],"about_ca_topic_score_codex":0.000009045995,"about_ca_topic_score_gemma":0.0000031344707,"teacher_disagreement_score":0.9306245,"about_ca_system_score_codex":0.0003908741,"about_ca_system_score_gemma":0.00070956873,"threshold_uncertainty_score":0.99948514},"labels":[],"label_agreement":null},{"id":"W3107175144","doi":"10.2174/1872213x14999201124195724","title":"Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents","year":2020,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Encephalitis; Intensive care medicine; Etiology; Viral encephalitis; Infectious disease (medical specialty); Immunology; Disease; Virus; Pathology","score_opus":0.14921964953519667,"score_gpt":0.4037452093218328,"score_spread":0.2545255597866361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107175144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015293711,0.97709966,0.0000077658015,0.00039332933,0.0011753847,0.0035096356,0.0006464112,0.00021172607,0.0016623512],"genre_scores_gemma":[0.000588601,0.9924328,0.000110161585,0.00019606689,0.00054715615,0.00047114267,0.0047927327,0.00013964258,0.00072174845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938332,0.0011023268,0.0026784765,0.0012363738,0.00066254206,0.00048708945],"domain_scores_gemma":[0.9960633,0.00025290676,0.0017620451,0.00094289193,0.00027080387,0.0007080343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042200627,0.0010551662,0.003203809,0.00045878618,0.00023494338,0.00016281933,0.00020417546,0.00063166604,0.00021573938],"category_scores_gemma":[0.00042564303,0.00079844554,0.0008244889,0.000764819,0.0001850555,0.0006717944,0.00012327393,0.00068976596,0.00013843218],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008770759,0.0020287049,0.001194345,0.0022032738,0.002656416,0.00006004413,0.00016572633,0.000008966647,7.114456e-7,0.0006253412,0.00028857795,0.99068016],"study_design_scores_gemma":[0.003349743,0.0010482235,0.004259229,0.010286757,0.0017433093,0.00009884652,0.000040399154,0.0000074492073,0.00002791739,0.00013344498,0.97843516,0.0005695477],"about_ca_topic_score_codex":0.00025223906,"about_ca_topic_score_gemma":0.0001412868,"teacher_disagreement_score":0.99011064,"about_ca_system_score_codex":0.0006046635,"about_ca_system_score_gemma":0.0011708337,"threshold_uncertainty_score":0.99944663},"labels":[],"label_agreement":null},{"id":"W3139664886","doi":"10.2174/1872213x13666181228154940","title":"Urinary Tract Infection in Children","year":2018,"lang":"en","type":"article","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Dysuria; Medicine; Urinalysis; Urinary system; Chills; Urine; Observational study; Clinical trial; Physical examination; Randomized controlled trial; Internal medicine","score_opus":0.014875733591496108,"score_gpt":0.2598871133553896,"score_spread":0.2450113797638935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139664886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921015,0.00017720225,0.000028308561,0.0023500812,0.00044802635,0.00039970718,0.0000058854557,0.000087569926,0.004401743],"genre_scores_gemma":[0.99036187,0.0069047036,0.00001897566,0.00079014106,0.0007981771,0.000055930654,0.0001421363,0.000018702347,0.00090935966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985567,0.00012217148,0.00040390305,0.00036042492,0.00023772956,0.00031910403],"domain_scores_gemma":[0.99937993,0.000052927575,0.00016164522,0.00024599122,0.0000900783,0.000069420814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023854208,0.000211956,0.00027233324,0.00033389125,0.00014299527,0.000015963426,0.00007049404,0.00017204127,0.0001857024],"category_scores_gemma":[0.000099737714,0.00018417297,0.00008244299,0.00028991734,0.00014459898,0.00038957928,0.000054848213,0.0002961083,0.00033701851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012790402,0.0011065082,0.98845184,0.000010083979,0.00038633356,0.000036008107,0.00026967708,0.00007333168,0.00032491662,0.00020287547,0.0023888142,0.005470551],"study_design_scores_gemma":[0.0021193458,0.00066831417,0.9884318,0.00002527155,0.00005341121,0.00007479072,0.0000151247095,0.000054617416,0.00092908257,0.00015943713,0.0073089874,0.0001597875],"about_ca_topic_score_codex":0.0000652448,"about_ca_topic_score_gemma":0.00006812614,"teacher_disagreement_score":0.0067275013,"about_ca_system_score_codex":0.00011907747,"about_ca_system_score_gemma":0.00007103398,"threshold_uncertainty_score":0.7510356},"labels":[],"label_agreement":null},{"id":"W4242876021","doi":"10.2174/1872213x113079990022","title":"Seasonal Allergic Rhinitis","year":2013,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BP (Canada); Alberta Children's Hospital","funders":"","keywords":"Medicine; rhinorrhea; Nasal congestion; Antihistamine; Nasal administration; Pharmacotherapy; Dermatology; Nasal spray; Corticosteroid; Allergy; Anesthesia; Nose; Internal medicine; Surgery; Immunology","score_opus":0.046943653567449894,"score_gpt":0.29526604709431514,"score_spread":0.24832239352686525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242876021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010010178,0.97103655,0.00014573794,0.00088193186,0.0017973656,0.0031447224,0.00016176744,0.0003061984,0.021524709],"genre_scores_gemma":[0.00010482368,0.96927404,0.00013247982,0.00033196562,0.0012351931,0.0004085175,0.0087899165,0.00022436792,0.019498697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442613,0.0004432788,0.0018549137,0.0010864219,0.0014550732,0.0007341866],"domain_scores_gemma":[0.9967667,0.00021252909,0.0012080298,0.00091970945,0.000456655,0.00043641203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030431192,0.0011283493,0.002444324,0.0005529268,0.0002451529,0.0003728386,0.00033369282,0.00065128645,0.0024537435],"category_scores_gemma":[0.00018249983,0.0008954571,0.0009932232,0.0005337646,0.00010354035,0.0007976589,0.00015364411,0.00086041196,0.0034409668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008679817,0.00026963805,0.000004927536,0.0036696764,0.0011768071,0.00019245296,0.0001107858,0.00007120447,0.000003630473,0.0019089049,0.017603677,0.9749015],"study_design_scores_gemma":[0.0011780935,0.00012027692,0.000065753,0.01511514,0.00039568834,0.00017039117,0.000057449437,0.0002474578,0.000011173404,0.00008591096,0.9817261,0.000826563],"about_ca_topic_score_codex":0.000031454554,"about_ca_topic_score_gemma":0.000015462809,"teacher_disagreement_score":0.97407496,"about_ca_system_score_codex":0.0006653756,"about_ca_system_score_gemma":0.00071471435,"threshold_uncertainty_score":0.9993496},"labels":[],"label_agreement":null},{"id":"W4252181618","doi":"10.2174/1872213x08666140704113452","title":"Seasonal and Perennial Allergic Conjunctivitis","year":2014,"lang":"en","type":"review","venue":"Recent Patents on Inflammation & Allergy Drug Discovery","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BP (Canada)","funders":"","keywords":"Medicine; Antihistamine; Allergic conjunctivitis; Dermatology; Refractory (planetary science); Allergy; Anesthesia; Immunology","score_opus":0.02677836925504434,"score_gpt":0.28310897648025735,"score_spread":0.256330607225213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252181618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009767247,0.9827875,0.000071711096,0.0006451044,0.0012525935,0.0014841252,0.00010019381,0.00013617938,0.0037553613],"genre_scores_gemma":[0.00064012327,0.99004817,0.000028506487,0.0002292081,0.0009614439,0.00014443108,0.0016609833,0.00012259351,0.006164546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656296,0.00034113106,0.0009361607,0.0008358388,0.0008220827,0.0005018518],"domain_scores_gemma":[0.99813384,0.00017089015,0.0006053168,0.00063057116,0.00014919383,0.0003101654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031707666,0.0007938143,0.00206304,0.00028440333,0.00015071122,0.0002052182,0.00018140995,0.0004250032,0.00038563274],"category_scores_gemma":[0.00010427862,0.0006285474,0.0006284334,0.00021454354,0.00008435642,0.00038254354,0.00013074036,0.0006361735,0.00051689416],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016993251,0.00015497471,0.000093243674,0.0055049234,0.0011315118,0.0000768015,0.00006041514,0.000009136592,0.0000058994465,0.001194606,0.0010323595,0.9905662],"study_design_scores_gemma":[0.0014040906,0.00016551296,0.00028867574,0.011688038,0.0005724843,0.00003278617,0.000028972203,0.000063439715,0.000010812281,0.000028112578,0.98513204,0.00058503554],"about_ca_topic_score_codex":0.000020673162,"about_ca_topic_score_gemma":0.000034279874,"teacher_disagreement_score":0.9899812,"about_ca_system_score_codex":0.00027773762,"about_ca_system_score_gemma":0.0004217722,"threshold_uncertainty_score":0.99961656},"labels":[],"label_agreement":null}]}